Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
| Conditions: | Malignant Mesothelioma |
| Start Date: | December 1, 2008 |
| Phase: | Phase II |
| Status: | Recruiting |
| NCT ID: | NCT00770120 |
| Study Type: | Interventional |
| Intervention: | Drug: everolimus |
| Study Design: | Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Southwest Oncology Group|National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 55 |
| Funded By: | Other|NIH |
| First Received: | October 8, 2008 |
| End Date: | |
| Last Updated: | January 12, 2011 |
| Last Verified: | January 1, 2011 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
